Travera
Biotechnology Research
200 Boston Ave.
13 employees
- Employees
- 13
- Contacts
- 4
- Emails
- 4
- Phones
- 3
Travera Overview
- Headquarters
- 200 Boston Ave.
- Website
- www.travera.com
- Industry
- Biotechnology Research
- Employees
- 13
- Founded
- 2017
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Travera
Travera uses a breakthrough measurement tool invented at MIT to directly measure which cancer drugs are most likely to be effective for each individual cancer patient prior to them taking the drugs. The company offers CLIA certified Rapid Therapy Guidance Tests for all major cancers and 100+ FDA-approved cancer drugs, with a turnaround time of only two days. *See if you qualify for FREE testing through Early Access: https://form.jotform.com/241784594580165
Travera Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 3
- 75.0% coverage
Travera Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Kou Qin, Phd | Investment Director @ Eisai Innovation | Cambridge, Massachusetts, United States |
Email
Phone
|
| Mark Stevens | Co-founder and CEO | Seattle, Washington, United States |
Email
|
| Selim Olcum | Weighs Cancer Cells for Personalized | Cambridge, Massachusetts, United States |
Email
Phone
|
| Dennis Watson | Commercial Leader//consultant//medical | Louisville Metropolitan Area, United States |
Email
Phone
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Director
1 profile
Compare Similar Companies to Travera
Exact Sciences
Biotechnology Research
NeoGenomics Laboratories
Hospitals And Health Care
Velsera
Biotechnology Research
Travere Therapeutics
Biotechnology
Complete Genomics
Biotechnology Research
Aganitha
Biotechnology Research
Novigenix SA
Biotechnology
Droplet Biosciences, Inc
Biotechnology
Claret Bioscience
Biotechnology Research
EazeBio
Biotechnology Research